KINIKSA PHARMACEUTICALS-A (KNSA)

BMG5269C1010 - Common Stock

19.24  +0.52 (+2.78%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
301.77M270.26M220.20M38.50M0.00
Cost Of Goods
36.96M33.41M22.90M9.10MN/A
Gross Profit
264.82M236.85M197.30M29.40MN/A
Operating Expenses
295.36M262.05M187.50M186.10M157.40M
Research and Development
87.27M76.10M65.50M99.30M112.00M
Selling, General, and Administrative Expenses
139.07M129.43M98.00M85.90M45.30M
Operating Income
-30.54M-25.20M9.80M-156.60M-157.40M
Interest Income/Expense
8.98M8.54M1.30M100.00K1.10M
Income Before Taxes
-21.57M-16.65M11.00M-156.50M-156.20M
Income Tax
-30.21M-30.74M-172.30M1.40M5.20M
Net Income
8.64M14.08M183.40M-157.90M-161.40M
EBITDA
-28.33M-22.86M12.20M-154.24M-154.99M
 
Per Share Data
EPS Diluted Total Ops
0.080.202.60-2.30-2.61
Non GAAP EPS
0.110.182.59-2.30-2.58
 
Statistics
Gross Profit Margin
87.75%87.64%89.60%76.36%N/A
Profit Margin
2.86%5.21%83.29%-410.13%N/A
Operating Profit Margin
-10.12%-9.32%4.45%-406.75%N/A

All data in USD

Charts